MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03372dam a22003494a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
0000068186 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
0001 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
151105s2009 enka b 001 0 eng d |
| 015 ## - NATIONAL BIBLIOGRAPHY NUMBER |
|---|
| National bibliography number |
GBA952543 |
| Source |
bnb |
| 016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER |
|---|
| Record control number |
015266541 |
| Source |
Uk |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781848440906 (hbk.) |
|
|---|
| International Standard Book Number |
1848440901 (hbk.) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)ocn360205341 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
UKM |
| Transcribing agency |
UKM |
| Modifying agency |
BWKUK |
| -- |
BWK |
| -- |
DLC |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
lccopycat |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
K3636 |
| Item number |
.A93 2009 |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
344.04233 |
| Edition number |
22 |
| 084 ## - OTHER CLASSIFICATION NUMBER |
|---|
| Classification number |
344.04233 |
| Item number |
ABB-G |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Abbott, Frederick M. |
| 245 10 - TITLE STATEMENT |
|---|
| Title |
Global pharmaceutical policy : |
| Medium |
[Book] : |
| Remainder of title |
ensuring medicines for tomorrow's world / |
| Statement of responsibility, etc. |
Frederick M. Abbott, Graham Dukes. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Northampton, MA : |
| -- |
Northampton, MA : |
| Name of publisher, distributor, etc. |
Edward Elgar, |
| Date of publication, distribution, etc. |
c2009. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
x, 308 pages. : |
| Other physical details |
ill. ; |
| Dimensions |
25 cm. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
The challenges we face -- Promoting innovation : patents, subsidies, prizes and prices -- Policies on innovation: past, present, and future -- The global regulatory environment : quality, safety, and efficacy -- Medicines for the developing world -- The use of medicines : education, information, and persuasion -- Regulation and the role of the courts -- Specialized policy areas : vaccines, biologicals, and blood products : alternative and traditional medicines : self-medication : counterfeit medicines -- The rich, the poor, and the neglected -- Global and regional policies : the way ahead. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
Pharmaceuticals play a central role in health care throughout the world. The pharmaceutical industry is beset with difficulties as increasing research and development expenditure yields fewer new treatments. Public and private budgets strain under the weight of high prices and limited access. The world's poor see little effort to address diseases prevalent in less affluent societies, while the world's wealthy are overusing prescription drugs, risking their health and wasting resources. As the global economic crisis exacerbates pressure on health care budgets, a new presidential administration in Washington, DC has committed to broad health care reform. These circumstances form the backdrop for this extraordinarily timely examination of the global system for the development, production, distribution and use of medicines. The authors are acknowledged experts in the fields of pharmaceutical law and policy, with many years experience advising governments, multilateral organizations and policy-makers on issues involving innovation, access and use of medicines. Supported by a team of independent scientists, doctors and lawyers, they take an insightful look at the issues surrounding global regulation of the pharmaceutical sector, and offer pragmatic suggestions for reform. This book will be of interest to government policy-makers, members of industry, healthcare professionals, teachers, students and lawyers in the fields of public health, intellectual property and international trade. |
| 521 ## - TARGET AUDIENCE NOTE |
|---|
| Target audience note |
All. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Drugs |
| General subdivision |
Law and legislation. |
|
|---|
| Topical term or geographic name entry element |
Pharmacy |
| General subdivision |
Law and legislation. |
|
|---|
| Topical term or geographic name entry element |
Pharmaceutical policy |
| General subdivision |
International cooperation. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Dukes, M. N. G. |
| Fuller form of name |
(Maurice Nelson Graham) |
| 852 ## - LOCATION |
|---|
| Accession No. |
52446 |
| -- |
1100.00 |
| -- |
New Public Books |
| Former shelving location |
Books |
